Holdings (as at 2026-04-10)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Organon & Co. 2.57%
Humana Inc. 2.42%
Elevance Health Inc. 2.32%
Globus Medical, Inc. (Class A) 2.29%
HCA Healthcare, Inc. 2.28%
Zimmer Biomet Holdings, Inc. 2.25%
Exelixis, Inc. 2.25%
Incyte Corporation 2.23%
Cardinal Health, Inc. 2.22%
The Cigna Group 2.22%
Universal Health Services, Inc. (Class B) 2.20%
Solventum Corporation 2.20%
Bio-Rad Laboratories, Inc. (Class A) 2.19%
DaVita Inc. 2.13%
Regeneron Pharmaceuticals, Inc. 2.11%
Biogen Inc. 2.06%
Encompass Health Corporation 1.93%
Molina Healthcare, Inc. 1.91%
Tenet Healthcare Corporation 1.80%
QIAGEN N.V. 1.78%
Chemed Corporation 1.78%
Merck & Co., Inc. 1.76%
Ionis Pharmaceuticals, Inc. 1.75%
Masimo Corporation 1.75%
Penumbra, Inc. 1.75%
Amgen Inc. 1.74%
Becton, Dickinson and Company 1.71%
United Therapeutics Corporation 1.68%
Pfizer Inc. 1.67%
Insmed Incorporated 1.65%
GE HealthCare Technologies Inc. 1.35%
Henry Schein, Inc. 1.34%
Revvity, Inc. 1.34%
ResMed Inc. 1.33%
Medtronic Plc 1.32%
Steris Plc 1.32%
The Cooper Companies, Inc. 1.30%
Gilead Sciences, Inc. 1.30%
Quest Diagnostics Incorporated 1.28%
Illumina, Inc. 1.28%
Labcorp Holdings Inc. 1.28%
Sarepta Therapeutics, Inc. 1.27%
Certara, Inc. 1.27%
Bristol-Myers Squibb Company 1.26%
Natera, Inc. 1.26%
UnitedHealth Group Incorporated 0.98%
Waters Corporation 0.94%
Halozyme Therapeutics, Inc. 0.92%
Eli Lilly and Company 0.89%
Medpace Holdings, Inc. 0.89%
Medline Inc. (Class A) 0.89%
Thermo Fisher Scientific Inc. 0.88%
Agilent Technologies, Inc. 0.88%
Align Technology, Inc. 0.88%
Zoetis Inc. 0.87%
IQVIA Holdings Inc. 0.86%
Johnson & Johnson 0.85%
Abbott Laboratories 0.85%
Neurocrine Biosciences, Inc. 0.85%
BioMarin Pharmaceutical Inc. 0.84%
Sotera Health Company 0.44%
Viking Therapeutics, Inc. 0.43%
Envista Holdings Corporation 0.43%
Stryker Corporation 0.42%
West Pharmaceutical Services, Inc. 0.42%
DexCom, Inc. 0.42%
Danaher Corporation 0.41%
IDEXX Laboratories, Inc. 0.41%
Royalty Pharma Plc (Class A) 0.41%
Boston Scientific Corporation 0.40%
Vertex Pharmaceuticals Incorporated 0.40%
Edwards Lifesciences Corporation 0.40%
Intuitive Surgical, Inc. 0.40%
Alnylam Pharmaceuticals, Inc. 0.40%
AbbVie Inc. 0.39%
Veeva Systems Inc. (Class A) 0.35%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.